FDA’s CBD Report to Congress Underscores Need for Regulations

While the U.S. Food and Drug Administration (FDA) has been tasked with regulating the cannabidiol (CBD) industry, the agency has repeatedly asserted it will not do so until it receives sufficient data on the cannabinoid’s safety for consumers. Yet, according to HempGrower, the agency’s latest report to Congress on July 8 evaluating the CBD marketplace underscores ...